Facebook
Twitter
Telegram
Report an ErrorAssembly Biosciences Financial Ratios 2011-2024 | ASMB
Annual Financial Ratios Assembly Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-1.0 | -0.1 | -0.5 | -3.2 | -4.8 | -5.5 | -20.7 | -7.4 | -2.8 | -2.5 | -3.9 | -1.3 | -2.4 |
P/S |
8.5 | - | 10.7 | 2.5 | 29.2 | 33.9 | 98.4 | - | - | - | - | - | - |
EPS |
-13.4 | -23.1 | -3 | -1.8 | -3.7 | -4.0 | -2.4 | -2.6 | -1.8 | -3.4 | -5 | -1.9 | -3.6 |
EV (Enterprise Value) |
137 M | -28.2 M | 43.6 M | 181 M | 486 M | 517 M | 862 M | 317 M | 68.3 M | 42.4 M | 51.6 M | 14.5 M | 49.7 M |
EBITDA per Share |
-14 | -23.2 | -3.06 | -1.8 | -3.89 | -4.04 | -2.93 | -2.62 | -1.88 | -3.42 | -5.05 | -9.76 | -17.7 |
EV/EBITDA |
-0.1 | -2.2 | -4.1 | -5.0 | -15.5 | -6.6 | -1.8 | -1.2 | -2.5 | -0.5 | -1.4 | ||
PEG |
-0.01 | -0.0 | -0.04 | -0.06 | -0.73 | 0.08 | -3.33 | 0.18 | -0.06 | -0.08 | -0.08 | -0.03 | -0.03 |
P/B |
1.5 | 0.1 | 0.4 | 0.8 | 1.7 | 2.4 | 7.8 | 4.1 | 0.7 | 1.0 | 3.1 | 1.8 | 2.4 |
P/CF |
2.7 | -0.1 | -0.7 | -3.0 | -5.4 | -7.7 | 891.7 | -9.3 | -4.3 | -3.9 | -4.3 | -1.5 | -3.4 |
ROE % |
-148.98 | -112.61 | -76.87 | -25.83 | -35.73 | -43.08 | -37.84 | -55.41 | -23.96 | -40.62 | -79.22 | -139.19 | -99.46 |
ROA % |
-44.75 | -91.45 | -67.97 | -21.94 | -28.72 | -33.86 | -25.29 | -45.11 | -21.27 | -33.40 | -71.52 | -120.60 | -92.71 |
ROCE % |
-157.30 | -113.85 | -78.55 | -25.03 | -32.56 | -37.16 | -33.52 | -49.76 | -22.75 | -34.14 | -80.04 | -139.56 | -98.46 |
Current Ratio |
1.4 | 5.3 | 8.6 | 9.2 | 11.6 | 12.0 | 9.1 | 7.5 | 20.1 | 27.7 | 10.3 | 7.5 | 14.7 |
DSO |
25.1 | - | 45.7 | 5.7 | 77.1 | 59.9 | 92.0 | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
25.1 | - | 45.7 | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
25.1 | - | 45.7 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Assembly Biosciences
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.66 | - | -0.27 | -0.32 | -4.46 | - | -0.48 | -0.51 | -0.48 | - | -0.41 | -0.55 | -0.69 | -1.11 | -0.09 | 0.21 | -0.76 | -0.99 | -0.96 | -0.72 | -1.05 | -1.03 | -0.87 | -1.3 | -0.8 | -160 | -710 | -780 | -810 | -0.67 | -0.67 | -0.59 | -0.64 | -0.45 | -0.38 | -0.41 | -0.64 | - | -1.33 | -0.52 | -0.92 | - | -1.23 | -1.2 | -0.22 | -0.29 | -0.41 | -0.59 | -0.66 | -1.52 | -0.5 | -0.97 | -0.38 |
EBITDA per Share |
-1.95 | - | - | - | -4.57 | - | -0.48 | -0.5 | -0.48 | - | -0.41 | -0.55 | -0.68 | - | -0.1 | 0.19 | -0.79 | - | -0.99 | -0.76 | -1.1 | - | -0.89 | -1.31 | -0.82 | - | -0.71 | -0.78 | -0.8 | - | -0.68 | -0.61 | -0.65 | - | -0.41 | -0.42 | -0.64 | - | -1.34 | -0.53 | -0.93 | - | -1.24 | -1.22 | -0.22 | - | -0.41 | -0.59 | -0.66 | - | -0.48 | -0.96 | -0.21 |
ROE % |
-127.73 | -92.26 | -114.86 | -102.90 | -91.88 | -58.06 | -66.43 | -52.20 | -42.65 | -29.55 | -45.94 | -38.96 | -25.76 | -25.83 | -19.36 | -27.12 | -36.91 | -35.73 | -38.24 | -39.32 | -45.27 | -43.08 | -33.32 | -33.95 | -33.24 | -37.84 | -49.64 | -53.28 | -53.97 | -55.41 | -47.48 | -38.57 | -31.70 | -23.96 | -36.25 | -49.49 | -47.86 | -29.98 | -49.91 | -51.03 | -66.21 | -54.53 | -75.82 | -85.96 | -108.50 | -139.19 | -172.52 | -159.25 | -137.47 | -99.46 | -16.80 | -20.16 | -7.88 |
ROA % |
-88.81 | -76.11 | -95.15 | -86.27 | -77.95 | -50.29 | -57.84 | -46.35 | -38.30 | -26.31 | -40.22 | -33.85 | -22.28 | -21.94 | -15.99 | -22.17 | -30.18 | -28.72 | -30.52 | -31.20 | -35.75 | -33.86 | -25.87 | -25.09 | -23.12 | -25.29 | -35.28 | -39.82 | -42.14 | -45.11 | -39.14 | -32.29 | -27.13 | -21.27 | -30.95 | -41.48 | -39.75 | -24.65 | -42.65 | -45.17 | -59.21 | -49.23 | -67.67 | -75.73 | -94.56 | -120.60 | -153.07 | -142.67 | -125.12 | -92.71 | -15.66 | -18.79 | -7.35 |
ROCE % |
- | - | -22.85 | -45.70 | -65.52 | -58.45 | -66.85 | -52.40 | -42.79 | -29.64 | -31.31 | -24.58 | -11.63 | -10.45 | -19.96 | -27.80 | -37.75 | -27.10 | -36.14 | -35.67 | -39.29 | -26.49 | -34.48 | -33.42 | -31.30 | -25.64 | -38.47 | -43.32 | -46.10 | -36.72 | -42.18 | -34.81 | -28.81 | -16.48 | -32.23 | -42.52 | -40.61 | -26.34 | -46.48 | -50.87 | -66.93 | -55.16 | -85.31 | -95.33 | -117.68 | -118.13 | -134.19 | -120.09 | -98.09 | -43.77 | -16.06 | -19.99 | -7.72 |
Current Ratio |
1.4 | 1.4 | 5.2 | 5.7 | 6.5 | 5.3 | 6.4 | 7.4 | 10.2 | 8.6 | 10.2 | 8.6 | 8.8 | 6.6 | 6.6 | 6.6 | 6.6 | 5.1 | 5.1 | 5.1 | 5.1 | 4.7 | 4.7 | 4.7 | 4.7 | 3.0 | 3.0 | 3.0 | 3.0 | 5.4 | 5.4 | 5.4 | 5.4 | 8.9 | 8.9 | 8.9 | 8.9 | 5.6 | 5.6 | 5.6 | 5.6 | 10.3 | 10.3 | 10.3 | 10.3 | 7.5 | 7.5 | 7.5 | 7.5 | 14.7 | 31.3 | 17.7 | - |
DSO |
0.7 | - | - | - | - | - | - | - | - | - | 7.8 | - | - | 108.2 | 3.2 | 2.9 | 51.5 | 64.6 | 72.8 | 100.0 | 68.2 | 59.4 | 51.7 | 68.9 | 60.2 | 62.6 | 78.0 | 87.9 | 151.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
0.7 | - | - | - | - | - | - | - | - | - | 7.8 | - | - | 108.2 | 3.2 | 2.9 | 51.5 | 64.6 | 72.8 | 100.0 | 68.2 | 59.4 | 51.7 | 68.9 | 60.2 | 62.6 | 78.0 | 87.9 | 151.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
0.7 | - | - | - | - | - | - | - | - | - | 7.8 | - | - | 108.2 | 3.2 | 2.9 | 51.5 | 64.6 | 72.8 | 100.0 | 68.2 | 59.4 | 51.7 | 68.9 | 60.2 | 62.6 | 78.0 | 87.9 | 151.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency